Prediction of mortality using dobutamine echocardiography.

[1]  R. Cole.  THE UNIVERSITY DEPARTMENT OF MEDICINE. , 1920, Science.

[2]  W. Kannel,et al.  Natural history of angina pectoris in the Framingham study. Prognosis and survival. , 1972, The American journal of cardiology.

[3]  G. Diamond,et al.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.

[4]  N. Nanda,et al.  Reproducibility of two-dimensional exercise echocardiography. , 1989, Journal of the American College of Cardiology.

[5]  A. Salustri,et al.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. , 1992, The American journal of cardiology.

[6]  J R Roelandt,et al.  Dobutamine Stress Echocardiography for Assessment of Perioperative Cardiac Risk in Patients Undergoing Major Vascular Surgery , 1993, Circulation.

[7]  C. Oakley,et al.  Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease. , 1993, The American journal of cardiology.

[8]  Robert Califf,et al.  Value of the History and Physical in Identifying Patients at Increased Risk for Coronary Artery Disease , 1993, Annals of Internal Medicine.

[9]  M. Quiñones,et al.  Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events. , 1994, American heart journal.

[10]  E. Picano,et al.  Detection of viable myocardium by dobutamine and dipyridamole stress echocardiography. , 1994, Herz.

[11]  P. Longère,et al.  Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months. , 1994, Journal of the American College of Cardiology.

[12]  J R Roelandt,et al.  Dobutamine-atropine stress echocardiography for assessment of perioperative and late cardiac risk in patients undergoing major vascular surgery. , 1994, European journal of vascular surgery.

[13]  J R Roelandt,et al.  Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. , 1994, The American journal of medicine.

[14]  J. Seward,et al.  Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. , 1995, Mayo Clinic proceedings.

[15]  G Germano,et al.  Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. , 1995, Journal of the American College of Cardiology.

[16]  I. R. Thomson,et al.  Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. , 1995, Journal of the American College of Cardiology.

[17]  N. Dawson,et al.  Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease. , 1995, The American journal of cardiology.

[18]  D. Bach,et al.  Dobutamine stress echocardiography. , 1992, American heart journal.

[19]  D. Berman,et al.  Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. , 1996, Circulation.

[20]  R Erbel,et al.  Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. , 1996, Journal of the American College of Cardiology.

[21]  W. Armstrong,et al.  Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease. , 1996, The American journal of cardiology.

[22]  Jeroen J. Bax,et al.  Assessment of myocardial viability by dobutamine stress echocardiography. , 1996, Current opinion in cardiology.

[23]  R. Califf,et al.  27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. , 1996, Journal of the American College of Cardiology.

[24]  H. Völler,et al.  Comparison of the prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease. , 1997, The American journal of cardiology.

[25]  T. Marwick.  Use of stress echocardiography for the prognostic assessment of patients with stable chronic coronary artery disease. , 1997, European heart journal.

[26]  I. Kronzon,et al.  Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study. , 1997, Journal of the American College of Cardiology.

[27]  J R Roelandt,et al.  Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. , 1997, Journal of the American College of Cardiology.

[28]  J. Seward,et al.  Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. , 1998, Journal of the American College of Cardiology.

[29]  J. Seward,et al.  Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. , 1998, Circulation.

[30]  Brown Ka.  Do stress echocardiography and myocardial perfusion imaging have the same ability to identify the low-risk patient with known or suspected coronary artery disease? , 1998 .

[31]  D. Berman,et al.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. , 1999, Journal of the American College of Cardiology.

[32]  D. Berman,et al.  The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. , 1999, The American journal of medicine.

[33]  T. Marwick,et al.  Myocardial doppler velocity responses to exercise correlate with independent evidence of ischemia by dual isotope SPECT , 1999 .

[34]  E J Topol,et al.  Cause of death in clinical research: time for a reassessment? , 1999, Journal of the American College of Cardiology.

[35]  A Garfinkel,et al.  Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease. , 1999, Journal of the American College of Cardiology.

[36]  D. Lipkin,et al.  Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease. , 1999, The American journal of cardiology.